(Q40488051)

English

Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

0 references

anti-retroviral agent

0 references

author name string

Bergersen BM

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sandvik L

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Bruun JN

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Tonstad S

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

publication date

28 July 2004

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

European Journal of Clinical Microbiology & Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

625-630

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

https://scigraph.springernature.com/pub.10.1007/s10096-004-1177-6

0 references

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fasting hyperinsulinemia and increased waist-to-hip ratios in non-wasting individuals with AIDS.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of dietary intervention on highly active antiretroviral therapy-related dyslipemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Significant decline in blood pressure levels after 1996--fact or artefact?]

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dietary influences on serum lipids and lipoproteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular disease risk profiles.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of a phase 2 clinical trial at 48 weeks (AI424-007): a dose-ranging, safety, and efficacy comparative trial of atazanavir at three doses in combination with didanosine and stavudine in antiretroviral-naive subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxicity of non-nucleoside analogue reverse transcriptase inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simplification with abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-infected patients with undetectable plasma HIV-1 RNA.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reliability of questionnaire information on cardiovascular disease and diabetes: cardiovascular disease study in Finnmark county

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naïve and HIV-negative controls: results from a Norwegian study of 721 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Body composition changes in 308 Norwegian HIV-positive patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination antiretroviral therapy and the risk of myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protease inhibitors and cardiovascular outcomes in patients with HIV-1

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protease inhibitor-associated hyperglycaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dietary advice with or without pravastatin for the management of hypercholesterolaemia associated with protease inhibitor therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of HIV infection and HAART on serum lipids in men.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of tenofovir on didanosine absorption in patients with HIV.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15322938

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10096-004-1177-6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40488051&oldid=1898113849"